verified SJR 0,666 · Q2 • database Scopus / SJR & DOAJ indexed

United States · John Wiley and Sons Ltd

workspace_premium Q2 — Oncology verified Plan S Compliant visibility_off Single blind Peer Review lock_open Open Access · DOAJ

Sarcoma

Sarcoma is a journal indexed in SJR in Oncology and Radiology, Nuclear Medicine and Imaging with an H index of 55. It is an CC BY Journal with a Single blind Peer Review review system, and It has a price of 697,5 €. The scope of the journal is focused on oncology, sarcoma. It has an SJR impact factor of 0,666 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,666.

ISSN: 1357-714X

Publisher: John Wiley and Sons Ltd

Category: Oncology

Indexation: verifiedScopus / SJR verifiedDOAJ

open_in_new Portal NPD menu_book Author guidelines

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

0,666 Q2

H-index 55

Acceptance rate pie_chart

31%

Source Acceptance_Rate

Time to publication hourglass_top

14 weeks

Field Average_time_publication_weeks

Publication cost (APC) payments

698 € Open Access

Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR DOAJ

SJR Impact

0,666

H-index

Docs (year)

Docs 3y

Total refs

175

Cites 3y

Citable 3y

Cites/Doc 2y

1.9

Ref/Doc

29.17

Immediate OA

697,5 €

Embargoed OA

NPD

Non OA / Submission

- €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Clinical and Histopathological Prognostic Factors in Chondrosarcomas

Wound Complications Following Resection of Adductor Compartment Tumours

Extraskeletal Osteosarcoma of the Orbit

EORTC Group Phase II Study of Oral Etoposide for Pretreated Soft Tissue Sarcoma

Enhanced MDM2 Oncoprotein Expression in Soft Tissue Sarcoma: Several Possible Regulatory Mechanisms

Distal Recurrence of Periosteal Osteosarcoma After Complete Excision of Proximal Primary Tumour With Good Excision Margins

Disease Incidence and Results of Extremity Lesion Treatment: Mersey Region Soft Tissue Sarcomas (1975-1985)

Diffuse Intramuscular Lipomatosis of a Lower Limb

Diagnosis and Treatment of Soft Tissue Tumours: The Dutch Nationwide-Accepted Consensus

Detection of EWS/FLI-1 by Immunostaining. An Adjunctive Tool in Diagnosis of Ewing's Sarcoma and Primitive Neuroectodermal Tumour on Cytological Samples and Paraffin-Embedded Archival Material

Desmoplastic Small Round Cell Tumour of Childhood: A Report of Four Cases Demonstrating Wider Clinical Features and Variable Outcome

CT and MR Imaging in the Local Staging of Primary Malignant Musculoskeletal Neoplasms: Report of the Radiology Diagnostic Oncology Group. Radiology 1997; 202:237-246

SHOW MORE ARTICLES

Comparison of the Outcome of Conventional Osteosarcoma at Two Specialist International Orthopaedic Oncology Centres

A Case of RhabdomyoSarcoma Following a Metal Surgical Implant

Clear Cell Chondrosarcoma of Bone

Chest Wall Sarcoma: Outcome in 22 Patients After Resection Requiring Thoracic Cage Reconstruction

Bilateral Endoprosthetic Replacements of the Proximal Femur

Assessment of Neurovascular Involvement by Malignant Musculoskeletal Tumors

aP2 Protein Expression as a Diagnostic Marker in Soft Tissue Tumours

Angiosarcoma of the Scalp Presenting in Association With Borderline Malignant Phyllodes Tumour of the Breast

Analysis of Lung Metastases in Patients with Primary Extremity Sarcoma

Alveolar Soft Part Sarcoma Metastatic to Small Bowel Mucosa Causing Polyposis and Intussuseption

Adult Pelvic Sarcomas: A Heterogeneous Collection of Sarcomas?

A Retrospective Clinicopathological Study of 37 Patients With Chordoma: A Danish National Series

FAQs

Sarcoma has an SJR of 0,666 (best quartile Q2) in the CountryOfPapers database.

Immediate OA APC is 697,5 EUR.

The acceptance rate recorded for Sarcoma is 31%.

Sarcoma

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Sarcoma?

What is the APC / publication cost?

What is the acceptance rate?